Correlation Between MAIA Biotechnology and Genscript Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MAIA Biotechnology and Genscript Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MAIA Biotechnology and Genscript Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MAIA Biotechnology and Genscript Biotech, you can compare the effects of market volatilities on MAIA Biotechnology and Genscript Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MAIA Biotechnology with a short position of Genscript Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of MAIA Biotechnology and Genscript Biotech.

Diversification Opportunities for MAIA Biotechnology and Genscript Biotech

0.54
  Correlation Coefficient

Very weak diversification

The 3 months correlation between MAIA and Genscript is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding MAIA Biotechnology and Genscript Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genscript Biotech and MAIA Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MAIA Biotechnology are associated (or correlated) with Genscript Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genscript Biotech has no effect on the direction of MAIA Biotechnology i.e., MAIA Biotechnology and Genscript Biotech go up and down completely randomly.

Pair Corralation between MAIA Biotechnology and Genscript Biotech

Given the investment horizon of 90 days MAIA Biotechnology is expected to generate 1.55 times more return on investment than Genscript Biotech. However, MAIA Biotechnology is 1.55 times more volatile than Genscript Biotech. It trades about 0.01 of its potential returns per unit of risk. Genscript Biotech is currently generating about -0.01 per unit of risk. If you would invest  354.00  in MAIA Biotechnology on August 25, 2024 and sell it today you would lose (146.00) from holding MAIA Biotechnology or give up 41.24% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

MAIA Biotechnology  vs.  Genscript Biotech

 Performance 
       Timeline  
MAIA Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MAIA Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Genscript Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genscript Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

MAIA Biotechnology and Genscript Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MAIA Biotechnology and Genscript Biotech

The main advantage of trading using opposite MAIA Biotechnology and Genscript Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MAIA Biotechnology position performs unexpectedly, Genscript Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genscript Biotech will offset losses from the drop in Genscript Biotech's long position.
The idea behind MAIA Biotechnology and Genscript Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Stocks Directory
Find actively traded stocks across global markets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio